USPTO Patents Application 10582583

Application No. 10/582,583
Amendment dated July 30, 2008
Reply to Office Action of April 30, 2008

Docket No.: 21046-00057-US1

AMENDMENTS TO THE CLAIMS

This listing of the claims will replace all prior versions and listings of the
claims in this application.

Listing of the Claims :

1 . (Currently amended) A medicament retaining sheet for a medicament blister
pack, said medic imcnt i flaming sheet comprising a first sheet having first and second faces and
a second sheet having first and second faces, wherein the first face of the second sheet and the
second face of the first sheet are opposed and bonded together and wherein the first sheet
includes lines of weakness defining a plurality- plurality of medicament release zones.

2. (Original) A medicament retaining sheet as claimed in Claim 1 wherein the lines
of weakness defining medicament release zones comprise a plurality of perforations and/or slits.

3. (Original) A medicament retaining sheet as claimed in Claim 2 wherein the lines
of weakness are formed in the first face of the first sheet.

4. (Previously presented) A medicament retaining sheet as claimed in Claim 1
wherein the lines of weakness extend from the first face of the first sheet, through the first sheet
and to the second face of said first sheet in at least a portion of each individual medicament
release zone.

5. (Previously presented) A medicament retaining sheet as claimed in claim 1,
wherein said medicament retaining sheet comprises a laminate.

6. (Previously presented) A medicament retaining sheet as claimed in claim 1
wherein at least portions of the second face of the second sheet are provided with a permanent
adhesive.

2

Application No. 10/582,583
Amendment dated July 30, 2008
Reply to Office Action of April 30, 2008

Docket No.: 21046-00057-US1

7. (Original) A medicament retaining sheet as claimed in Claim 5 wherein the
second face of the second sheet is fully coated with a permanent adhesive.

8. (Original) A medicament retaining sheet as claimed in Claim 5 wherein the
second face of the second sheet is provided with no permanent adhesive in the medicament
release zones.

9. (Previously presented) A medicament retaining sheet as claimed in claim 1
wherein the second sheet is formed from a metal foil or a metallized plastics material.

10. (Previously presented) A medicament retaining sheet as claimed in claim 1
wherein the first sheet is formed from a paper material.

11. (Previously presented) A medicament retaining sheet as claimed in claim 1,
wherein the medicament retaining sheet is for use in the manufacture of a medicament blister
pack.

12. (Currently amended) The use-e fmcthod of manufacturing a medicament blister
pack compi - 1 -;a medicament retaining sheet according to claim 1 in the ma n ufacture

13. (Previously presented) A medicament blister pack comprising a medicament
retaining sheet according to claim 1 .

14. (Previously presented) A blister pack as claimed in Claim 13 wherein the
medicament tray comprises a molded plastics or metallized tray including a plurality of
medicament cavities.

15. (Currently amended) A label for a medicament blister pack comprising a
medicament tray having a plurality of molded cavities or recesses each containing a medicant
medicament in the form of a capsule or tablet, said capsules or tablets being held in place by
means of a retaining sheet, wherein said label has a has first and second faces, said first face

3

Application No. 10/582,583
Amendment dated July 30, 2008
Reply to Office Action of April 30, 2008

Docket No.: 21046-00057-US1

having an adhesive applied thereto and wherein said label includes lines of weakness defining a
plurality of medicament release zones.

16. (Original) A label as claimed in Claim 15 wherein the lines of weakness defining
medicament release zones comprise a plurality of perforations and/or slits.

17. (Previously presented) A label as claimed in Claim 15 wherein the lines of
weakness extend from the upper surface, through the label, to the lower surface of said label in at
least a portion of each individual medicament release zone.

18. (Previously presented) A label as claimed in Claim 15 wherein the lines of
weakness are formed in the second face of the label.

19. (Previously presented) A label as claimed in Claim 15 wherein at least portions
of the second face of the second sheet are provided with a permanent adhesive.

20. (Previously presented) A label as claimed in Claim 19 wherein no adhesive is
applied to the first face in the medicament release zones.

21. (Previously presented) A label as claimed in Claim 15 wherein the first face is
fully coated with a permanent adhesive.

22. (Previously presented) A label as claimed in Claim 15 wherein the label is
formed from a paper material.

4